Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Abbott to Settle Lawsuit Over HIV Drug Pricing
Link ID 7402
Title Abbott to Settle Lawsuit Over HIV Drug Pricing
Url http://www.medscape.com/viewarticle/578409?src=rss
Description Abbott Laboratories has agreed to pay between $10 million and $27.5 million to settle a lawsuit contending it improperly raised the price of its HIV drug Norvir by 400 percent. Reuters Health Information
Category Articles > HIV/AIDS
Keywords
Date Aug 5, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > HIV/AIDS
1. Update on Epidemiologic Trends in HIV, Viral Hepatitis, and STDs
  Here Dr. Michael L. Tapper highlights the presentations from CROI 2008 regarding the epidemiology of HIV and changing patterns of HIV transmission as well as the epidemiology of hepatitis and STDs.
Category:   Articles > HIV/AIDS


2. Does Patient–Provider Racial/Ethnic Concordance Influence Ratings of Trust in People with HIV Infec
  Trust could impact the racial/ethnic disparities seen in HIV-related mortality. Here concordance was associated with lower mistrust in the healthcare system but not with greater trust in the provider.
AIDS and Behavior
Category:   Articles > HIV/AIDS


3. Sexual Difficulties in People Living with HIV in France - Results from a Large Representative Sample
  Sexual difficulties in a nationally representative sample of HIV-infected outpatients in France were analyzed.
AIDS and Behavior
Category:   Articles > HIV/AIDS


4. Cellulose Gel May Increase Vaginal HIV Transmission
  The results of a randomized trial conducted in Africa and India indicates that a vaginal gel containing the HIV-entry inhibitor cellulose sulfate is not effective in preventing transmission of the virus. In fact, it may actually increase the risk of acquisition. Reuters Health Information
Category:   Articles > HIV/AIDS


5. Risk of Side-effects Associated With the Use of Nevirapine in Treatment-naïve Patients, With Re
  A warning for Nevirapine has been issued, and recommends that Nevirapine not be prescribed in patients with increased risk of toxicity based on CD4 cut-offs and gender.
HIV Medicine
Category:   Articles > HIV/AIDS




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS